Actively Recruiting
IL-6 and Hemogram-Derived Inflammatory Indices for Mortality Prediction in Postoperative ICU Patients
Led by Ezgi Günaydın · Updated on 2026-03-10
42
Participants Needed
1
Research Sites
12 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective observational cohort study aims to evaluate the predictive value of interleukin-6 (IL-6) levels and hemogram-derived inflammatory scores for morbidity and in-hospital mortality in postoperative patients admitted to the intensive care unit (ICU). IL-6 levels and inflammatory indices will be assessed at ICU admission and at 24 hours using data obtained from routine clinical care. Associations between these biomarkers and clinical outcomes, including mortality, morbidity, antibiotic use, and duration of mechanical ventilation, will be evaluated after adjustment for illness severity.
CONDITIONS
Official Title
IL-6 and Hemogram-Derived Inflammatory Indices for Mortality Prediction in Postoperative ICU Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 63 18 years
- Postoperative patients admitted to the ICU
- Availability of complete clinical and laboratory data at ICU admission and at 24 hours
- Provision of informed consent by the patient or legally authorized representative
You will not qualify if you...
- Age < 18 years
- Thoracic surgery patients
- Cardiac surgery patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Recep Erin
Trabzon, Turkey (Türkiye)
Actively Recruiting
Research Team
E
Ezgi Günaydın, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here